Research Paper Volume 15, Issue 18 pp 9779—9796
Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer
Figure 11. Cellular functions of NDC1 in pancreatic cancer. (A) Western blot and (B) Real-time quantitative PCR detection after siRNA mediated knockdown of NDC1 in BxPC-3 and MIA PaCa-2 cells. (C) MTT assays. (D) Scratch assays. (E) EdU assays. (F) Cell apoptosis assays. *P < 0.05.